Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
about
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsEndocrine causes of nonalcoholic fatty liver diseaseNon-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval PathwayNon-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatmentEffects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: Magnetic Resonance Imaging Is an Effective, Non-invasive Method to Evaluate Changes in the Liver Fat Fraction.Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.Steatosis and steatohepatitis: complex disorders.Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetesAnthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methodsPattern of liver function tests in morbidly obese Saudi patients undergoing bariatric surgeryNoninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis.Serum autotaxin is independently associated with hepatic steatosis in women with severe obesity.Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals.Non-alcoholic fatty liver disease among sasang constitutional types: a population-based study in KoreaTreating nonalcoholic fatty liver disease.Utility of Ultrasound, Transaminases, and Visual Inspection to Assess Nonalcoholic Fatty Liver Disease in Bariatric Surgery Patients.Liver histology according to the presence of metabolic syndrome in nonalcoholic fatty liver disease cases.Fatty liver disease in severe obese patients: diagnostic value of abdominal ultrasound.Hepatic fatty acid trafficking: multiple forks in the roadAcylated and desacyl ghrelin are associated with hepatic lipogenesis, β-oxidation and autophagy: role in NAFLD amelioration after sleeve gastrectomy in obese rats.Insulin sensitizers for the treatment of non-alcoholic fatty liver diseaseLeptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice.Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease.Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review.Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis.Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice.Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis.HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.Hepatic angiogenesis and fibrosis are common features in morbidly obese patients.Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease.Nonalcoholic steatohepatitis on preoperative period of gastric bypass: lack of correlation with degree of obesity.Non-Alcoholic Fatty Liver Disease in Africa and Middle East: An Attempt to Predict the Present and Future Implications on the Healthcare System.Influence of type 2 diabetes mellitus on liver histology among morbidly obese individuals. A cross-sectional study.Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.Nonalcoholic Fatty Liver Disease in Morbidly Obese Subjects: Correlation Among Histopathologic Findings, Biochemical Features, and Ultrasound EvaluationCan nonalcoholic steatohepatitis be diagnosed without liver biopsy?
P2860
Q22299426-33DA5A8C-85DD-473A-A447-0BC34D290447Q26780254-E1517CC2-F000-44D3-B98E-5D559F40C01BQ26800894-16018E0E-9FD6-4EE9-971A-AB81C597FCC5Q26852019-1A01F0E6-5166-4901-B2E5-FDC69899202AQ31153508-6CF14A13-08BC-425E-8C0E-5B158D6615D7Q33263279-D261058A-6D26-48CA-B8AF-D4D283FF86A7Q33907632-B2A03E38-B808-4C23-A75D-2A0B95DE8C81Q34205386-10B3F51E-074F-45E1-AF37-8D45752A22C6Q34746071-71304D99-2B11-4B0E-8FF5-2CCF95B5AB92Q35098356-2C5AE2B8-7B0B-46CE-9C83-890A53C012E7Q35233535-58927DC1-1A5A-40D7-BA7A-5A66EA6159B1Q35553828-856F82A6-252C-4229-B5F2-609199A9DB02Q35668934-5A37457D-2A2E-45BA-BAC6-6C19029D7300Q35835264-07B00C08-EEFF-4AC7-87F8-4FC2CBB33355Q36962239-687B8EE1-477F-4661-AC17-086F0DD1DCBCQ37028786-514B5EC8-ADEC-4667-8164-27275DA65CB7Q37127107-7CFC75B7-AD63-4A20-A635-84CF0C5B562EQ37220693-72C47245-942F-4355-85B2-8E565AE0F993Q37296476-B1AB87A0-9227-4406-AA59-BAEA5615B004Q37529340-937A9A31-A774-48D1-9F81-A21CD5F68CDFQ38209666-7727937C-0CCD-4130-9569-13DCE3C3A2CDQ38297738-A7B2D0D4-F57A-49C8-91CA-19EDF3C90D40Q38772737-CDAFD7BF-EBAA-469B-BFAA-19DD5DBBAB8CQ39180598-077B38D8-AA67-4192-BDF0-EFCBEAC2BE16Q39341139-6B6EB519-AD20-47A2-A3C4-A6ADB97EA467Q39379029-F718EE26-C72A-4329-900B-0791D018F811Q41094296-750861ED-E2F8-4169-A8AB-420BEFE8CC48Q41445365-AD71ED00-6F94-492F-B41C-DB1E92A4BB35Q41487407-A51DECA2-022A-4111-BEE6-B279449293B5Q41528078-315A68B1-0BE9-4822-B208-31646F767080Q41872219-8FEEA389-FA4C-405D-A00D-A87BE01DFC13Q43212779-CC0ADE0D-8F03-4158-81AA-A1C645F71329Q43678877-995855A9-DDBE-400A-AA07-7A9865A316A2Q44006284-082B1DE5-F6EF-47B8-98D2-923E7F09649CQ46860543-FCF51162-C197-4D64-9402-D327AE57C826Q48881089-0C99997C-CF48-4A6C-BC3F-C765D8CDDAB4Q51373445-07ED987A-3657-431E-AB3F-0C06840EBBD2Q51391212-75C4A7AD-2048-41D9-B39F-B12D9A48F69EQ57781574-EF02ED7A-165D-4FD3-9FDE-3585FA61FF5DQ58622671-8315A819-CE79-4D82-AC9A-1A833D6C61C2
P2860
Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Predictors of nonalcoholic ste ...... nts undergoing gastric bypass.
@en
Predictors of nonalcoholic steatohepatitis
@nl
type
label
Predictors of nonalcoholic ste ...... nts undergoing gastric bypass.
@en
Predictors of nonalcoholic steatohepatitis
@nl
prefLabel
Predictors of nonalcoholic ste ...... nts undergoing gastric bypass.
@en
Predictors of nonalcoholic steatohepatitis
@nl
P2093
P356
P1433
P1476
Predictors of nonalcoholic ste ...... nts undergoing gastric bypass.
@en
P2093
Alejandro Raddatz
Alejandro Soza
Arnoldo Riquelme
Camilo Boza
Enrique Norero
Ignacio Duarte
Jose Ignacio Fernandez
Luis Ibañez
Marco Arrese
Paola Viviani
P2888
P304
P356
10.1381/0960892055002347
P577
2005-09-01T00:00:00Z
P6179
1010656165